Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl-Heinz Weiss

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
The Clinical Biochemist. Reviews|June 18, 2019
Biochemical Markers for the Diagnosis and Monitoring of Wilson DiseaseIsabelle Mohr, Karl Heinz Weiss
Annals of the New York Academy of Sciences|April 24, 2014
Clinical considerations for an effective medical therapy in Wilson's diseaseKarl Heinz Weiss, Wolfgang Stremmel
Handbook of Clinical Neurology|April 24, 2017
Genetic and environmental modifiers of Wilson diseaseValentina Medici, Karl-Heinz Weiss
Current Gastroenterology Reports|November 16, 2011
Evolving perspectives in Wilson disease: diagnosis, treatment and monitoringKarl Heinz Weiss, Wolfgang Stremmel
Annals of Translational Medicine|June 11, 2019
Current anti-copper therapies in management of Wilson diseaseIsabelle Mohr, Karl Heinz Weiss
Handbook of Clinical Neurology|April 24, 2017
Wilson disease: symptomatic liver therapyJan Pfeiffenberger, Karl-Heinz Weiss, Wolfgang Stremmel
Handbook of Clinical Neurology|April 24, 2017
Novel perspectives on Wilson disease treatmentChristian Rupp, Wolfgang Stremmel, Karl-Heinz Weiss
The Lancet. Neurology|December 16, 2014
Wilson's disease and other neurological copper disordersOliver Bandmann, Karl Heinz Weiss, Stephen G Kaler
Expert Opinion on Investigational Drugs|May 29, 2018
WTX101 - an investigational drug for the treatment of Wilson diseaseKarl Heinz Weiss, Anna Członkowska, Peter Hedera, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|March 19, 2025
Prospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment With Trientine Dihydrochloride in Patients With Wilson DiseaseIsabelle Mohr, Carlot Kruse, Verena Aliane, et al.
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
The Clinical Biochemist. Reviews|June 18, 2019
Biochemical Markers for the Diagnosis and Monitoring of Wilson DiseaseIsabelle Mohr, Karl Heinz Weiss
Annals of the New York Academy of Sciences|April 24, 2014
Clinical considerations for an effective medical therapy in Wilson's diseaseKarl Heinz Weiss, Wolfgang Stremmel
Handbook of Clinical Neurology|April 24, 2017
Genetic and environmental modifiers of Wilson diseaseValentina Medici, Karl-Heinz Weiss
Current Gastroenterology Reports|November 16, 2011
Evolving perspectives in Wilson disease: diagnosis, treatment and monitoringKarl Heinz Weiss, Wolfgang Stremmel
Annals of Translational Medicine|June 11, 2019
Current anti-copper therapies in management of Wilson diseaseIsabelle Mohr, Karl Heinz Weiss
Handbook of Clinical Neurology|April 24, 2017
Wilson disease: symptomatic liver therapyJan Pfeiffenberger, Karl-Heinz Weiss, Wolfgang Stremmel
Handbook of Clinical Neurology|April 24, 2017
Novel perspectives on Wilson disease treatmentChristian Rupp, Wolfgang Stremmel, Karl-Heinz Weiss
The Lancet. Neurology|December 16, 2014
Wilson's disease and other neurological copper disordersOliver Bandmann, Karl Heinz Weiss, Stephen G Kaler
Expert Opinion on Investigational Drugs|May 29, 2018
WTX101 - an investigational drug for the treatment of Wilson diseaseKarl Heinz Weiss, Anna Członkowska, Peter Hedera, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|March 19, 2025
Prospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment With Trientine Dihydrochloride in Patients With Wilson DiseaseIsabelle Mohr, Carlot Kruse, Verena Aliane, et al.
Pageof 18